关注
Ekramy Sayedahmed
Ekramy Sayedahmed
Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West
在 purdue.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Vaccine approaches conferring cross-protection against influenza viruses
SV Vemula, EE Sayedahmed, S Sambhara, SK Mittal
Expert review of vaccines 16 (11), 1141-1154, 2017
702017
Adenoviral vector-based vaccine platforms for developing the next generation of influenza vaccines
EE Sayedahmed, A Elkashif, M Alhashimi, S Sambhara, SK Mittal
Vaccines 8 (4), 574, 2020
602020
Progress towards the development of a universal influenza vaccine
WC Wang, EE Sayedahmed, S Sambhara, SK Mittal
Viruses 14 (8), 1684, 2022
302022
Current use of adenovirus vectors and their production methods
EE Sayedahmed, R Kumari, SK Mittal
Viral Vectors for Gene Therapy: Methods and Protocols, 155-175, 2019
262019
A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
A Khan, EE Sayedahmed, VK Singh, A Mishra, S Dorta-Estremera, ...
Cell Reports Medicine 2 (8), 2021
242021
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
AO Hassan, O Amen, EE Sayedahmed, SV Vemula, S Amoah, I York, ...
PLoS One 12 (10), e0186244, 2017
202017
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy
EE Sayedahmed, R Kumari, S Shukla, AO Hassan, SI Mohammed, ...
Vaccine 36 (45), 6744-6751, 2018
192018
Significance of preexisting vector immunity and activation of innate responses for adenoviral vector-based therapy
WC Wang, EE Sayedahmed, SK Mittal
Viruses 14 (12), 2727, 2022
172022
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
A Elkashif, M Alhashimi, EE Sayedahmed, S Sambhara, SK Mittal
Clinical & Translational Immunology 10 (10), e1345, 2021
172021
A bovine adenoviral vector-based H5N1 influenza-vaccine provides enhanced immunogenicity and protection at a significantly low dose
EE Sayedahmed, AO Hassan, R Kumari, W Cao, S Gangappa, I York, ...
Molecular Therapy Methods & Clinical Development 10, 210-222, 2018
162018
Nonhuman adenoviral vector-based platforms and their utility in designing next generation of vaccines for infectious diseases
M Alhashimi, A Elkashif, EE Sayedahmed, SK Mittal
Viruses 13 (8), 1493, 2021
142021
Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine
EE Sayedahmed, MV Araújo, TT Silva-Pereira, SK Chothe, A Elkashif, ...
Molecular Therapy-Methods & Clinical Development 30, 194-207, 2023
32023
miRNome expression analysis in canine diffuse large B-cell lymphoma
NO Elshafie, M Gribskov, NI Lichti, EE Sayedahmed, MO Childress, ...
Frontiers in Oncology 13, 1238613, 2023
32023
Nested PCR Detection of Pythium sp. from Formalin-Fixed, Paraffin-Embedded Canine Tissue Sections
NO Elshafie, J Hanlon, M Malkawi, EE Sayedahmed, LF Guptill, ...
Veterinary Sciences 9 (8), 444, 2022
32022
A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations
EE Sayedahmed, SK Mittal
Canadian Journal of Veterinary Research 84 (4), 314-318, 2020
32020
Development of NP-Based Universal Vaccine for Influenza A Viruses
EE Sayedahmed, NO Elshafie, AP Dos Santos, C Jagannath, ...
Vaccines 12 (2), 157, 2024
2024
Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector
EE Sayedahmed, NO Elshafie, GJ Zhang, SI Mohammed, S Sambhara, ...
Frontiers in Immunology 14, 1305937, 2023
2023
Method and composition against virus infections with activated innate lymphoid cells (ilcs)
M Suresh, S Sambhara, W Cao, W Mboko, E Sayedahmed
US Patent App. 17/409,962, 2022
2022
Adenovirus Vector-based Vaccine Approach for Emerging Influenza Viruses
EE Sayedahmed
Purdue University, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–19